-
EP3426676
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3426676
| EP3426676 - HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.01.2022 Database last updated on 18.11.2024 | |
| Former | Examination is in progress Status updated on 24.01.2020 | ||
| Former | Request for examination was made Status updated on 14.12.2018 | ||
| Former | The international publication has been made Status updated on 15.09.2017 | ||
| Former | unknown Status updated on 05.04.2017 | Most recent event Tooltip | 28.01.2022 | Application deemed to be withdrawn | published on 02.03.2022 [2022/09] | Applicant(s) | For all designated states Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [2019/03] | Inventor(s) | 01 /
CHI, Xiaoyuan Sherry 210 Jefferson Avenue Tenafly, New Jersey 07670 / US | 02 /
YANG, Xinzhen 2 Olde English Court Woodcliff Lake, New Jersey 07677 / US | [2019/03] | Representative(s) | Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR | [2019/03] | Application number, filing date | 17713783.3 | 09.03.2017 | [2019/03] | WO2017IB51401 | Priority number, date | US201662307423P | 11.03.2016 Original published format: US 201662307423 P | [2019/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017153954 | Date: | 14.09.2017 | Language: | EN | [2017/37] | Type: | A1 Application with search report | No.: | EP3426676 | Date: | 16.01.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.09.2017 takes the place of the publication of the European patent application. | [2019/03] | Search report(s) | International search report - published on: | EP | 14.09.2017 | Classification | IPC: | C07K14/005 | [2019/03] | CPC: |
C07K14/005 (EP);
C12N2710/16122 (EP);
C12N2710/16134 (EP);
C12N2710/16171 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/03] | Title | German: | GB-POLYPEPTID DES HUMANEN CYTOMEGALOVIRUS | [2019/03] | English: | HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE | [2019/03] | French: | POLYPEPTIDE GB DE CYTOMÉGALOVIRUS HUMAIN | [2019/03] | Entry into regional phase | 11.10.2018 | National basic fee paid | 11.10.2018 | Designation fee(s) paid | 11.10.2018 | Examination fee paid | Examination procedure | 29.08.2018 | Amendment by applicant (claims and/or description) | 11.10.2018 | Examination requested [2019/03] | 11.10.2018 | Date on which the examining division has become responsible | 28.01.2020 | Despatch of a communication from the examining division (Time limit: M06) | 06.11.2020 | Reply to a communication from the examining division | 01.10.2021 | Application deemed to be withdrawn, date of legal effect [2022/09] | 27.10.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2022/09] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 06.11.2020 | Request for further processing filed | 06.11.2020 | Full payment received (date of receipt of payment) Request granted | 17.11.2020 | Decision despatched | Fees paid | Renewal fee | 01.04.2019 | Renewal fee patent year 03 | 31.03.2020 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.03.2021 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XYI]WO2012049317 (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [X] 1-4,11-13,16,18-25 * page 3, lines 10-26 * * page 11, line 15 - page 13, line 21 * * page 19, line 32 - page 20, line 9 * * page 21, lines 1-7 * * page 38, line 6 - page 40, line 3; examples 1,2 * [Y] 5-10,14,15 [I] 17; | [XPY]EP3031822 (NOVARTIS AG [CH]) [XP] 1-4,11-13,16,18-25 * paragraphs [0025] , [0028] , [0036] , [0037] , [0093] , [0162] , [ 166]; figure 1; example 1; claims 1-6 *[Y] 5-8; | [XY] - "Cytomegalovirus glycoprotein B (gB)-SLP12-Delta725 polypeptide, SEQ 10.", Geneseq, (20120607), Database accession no. AZV29616, URL: EBI, XP002769687 [X] 1-4 * the whole document * [Y] 5-8 | [XY] - Davison, "Envelope glycoprotein B, human cytomegalovirus", UniProt, (20140319), Database accession no. V9LN55, XP002769688 [X] 1-4 * the whole document * [Y] 5-8 | [XY] - Tarantal, "Envelope glycoprotein B, Macanine betaherpesvirus 3, Rhesus cytomegalovirus", UniProt, (20100615), Database accession no. D5KB35, XP002769689 [X] 3,4 * the whole document * [Y] 9,10 | [Y] - SAPNA SHARMA ET AL, "HCMV gB shares structural and functional properties with gB proteins from other herpesviruses", VIROLOGY, (20121022), vol. 435, no. 2, doi:10.1016/j.virol.2012.09.024, ISSN 0042-6822, pages 239 - 249, XP055192519 [Y] 1-25 * page 243, column l, paragraph 4 - column r, paragraph 3; figure 4 * * page 245, column r, paragraph 2 - page 246, column l, paragraph 1 * DOI: http://dx.doi.org/10.1016/j.virol.2012.09.024 | [Y] - GALE SMITH ET AL, "Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats", PLOS ONE, (20121130), vol. 7, no. 11, doi:10.1371/journal.pone.0050852, ISSN 1932-6203, page e50852, XP055060314 [Y] 1-25 * page 4, column r, paragraphs 2-4; figure 1 * DOI: http://dx.doi.org/10.1371/journal.pone.0050852 | by applicant | WO9014837 | WO2010007533 | US2016280770 | - BURKE ET AL., PLOS PATHOG., (201510), vol. 11, no. 10 | - SHARMA ET AL., VIROLOGY, (20130120), vol. 435, no. 2, pages 239 - 49 |